NFKB1 and acute myeloid leukemia: In AML cells, FLT3 directly activates IKK and subsequently canonical NF-κB pathway, as well as FL3-ITD that is able to activate the TGF-β-activated kinase 1 (TAK1) that enhances NF-κB activation [130, 131].